MAKERS OF SUBOXONE TO PAY $1.4 BILLION N CIVIL AND CRIMINAL PENALTIES

1. 2019-07-13 at 2:12 PM UTC

   #1
   The Self Taught Man Black Hole

   […] On April 9, a federal grand jury in Virginia indicted Indivior for "allegedly engaging in an illicit nationwide scheme to increase prescriptions of Suboxone," according to the DOJ. The company denied the charges and trial is scheduled to start in May 2020.
   
   
   Federal prosecutors charged that Indivior allegedly marketed a version of Suboxone (Suboxone Film) to medical professionals as less addictive and safer than other drugs containing its active ingredient, the opioid buprenorphine, according to the DOJ statement.
   
   Prosecutors also charged that Indivior promoted the company's "Here to Help" web and phone program as a resource for opioid-addiction patients, which they alleged was actually a method of connecting those patients to doctors the company knew were already prescribing Suboxone and other opioids "to more patients than allowed by federal law, at high doses, and in a careless and clinically unwarranted manner," the DOJ statement said.
   
   
   In addition, the government charged that Indivior announced it would discontinue its tablet form of Suboxone "based on supposed 'concerns regarding pediatric exposure' to tablets, despite Indivior executives’ knowledge that the primary reason for the discontinuance was to delay the Food and Drug Administration’s approval of generic tablet forms of the drug," according to the DOJ statement.
   
   In a statement, Invidior noted its former parent company's settlement.
   
   "Indivior PLC’s case with the US Department of Justice (DOJ) is separate from that of RB, and Indivior has no additional or new information related to this matter," the statement read.
   
   As part of the settlement on Thursday, Invidior's former parent company RB Group agreed to a non-prosecution agreement and to forfeit $647 million of proceeds it received from Indivior. It also agreed to not manufacture, market, or sell Schedule I, II, or III controlled substances in the U.S. for three years and to cooperate with future investigations related to Suboxone.
   
   The trial against the RB Group's former subsidiary Invidior is still slated to start next May. Thursday's settlement was only with RB Group, and not Indivior.
   
   https://www.google.com/amp/s/abcnews.go.com/amp/Business/suboxone-maker-reckitt-benckiser-pay-14-billion-largest/story%3fid=64274260

   
   "Pediatric concerns" with tablets. Yeah, I guess literally any tablet drug in America could be pulled for that reason.
   
   Not that there was a doubt in my mind that Suboxone makers were dirty shitbags, but at least the public will know this as well now, and maybe doctors will stop putting the Roshambos of the world on 32mg maintentance doses. But probably not.
2. 2019-07-13 at 2:13 PM UTC

   #2
   

   OG_GREENPLASTIC_JOHNSON_III African Astronaut
3. 2019-07-13 at 2:17 PM UTC

   #3
   

   Ghost Black Hole
   release! the! patent!
   
   release! the! patent!
4. 2019-07-14 at 2:37 PM UTC

   #4
   The Self Taught Man Black Hole
   I
5. 2019-07-14 at 2:52 PM UTC

   #5
   

   -SpectraL coward [the spuriously bluish-lilac bushman]
   What a joke. That's like a billionaire dropping a nickle into a homeless person's cup and then walking away thinking they did something really great. It's actually more pathetic than it is funny.
6. 2019-07-14 at 2:54 PM UTC

   #6
   

   -SpectraL coward [the spuriously bluish-lilac bushman]
   And so-called "non-prosecution agreements" are illegal. A "non-prosecution agreement" is basically a nicer term for legalized bribery and obstruction of justice.
7. 2019-07-14 at 3:26 PM UTC

   #7
   

   Sophie Pedophile Tech Support
   Lol nice.